Content
- National Cardiovascular Laboratory
- The Future Health Competence Centre at Semmelweis University
- Development of an AI-based drug discovery platform: microRNA therapy for cardiometabolic and oncology diseases
- MicroRNA therapy development for cardiometabolic and oncological diseases
- Translational research and innovation in the diagnosis and treatment of ischemic heart disease and its comorbidities
- Molecular Mechanisms of Cardiological and Onco-Cardiological Diseases: Diagnostic and Therapeutic Investigations
- The Role of Inflammatory Mechanisms in Heart Failure and Cardiac Dysfunction Associated with Non-Alcoholic Steatohepatitis (NASH)
- The Effect of Metabolic Diseases on Extracellular Vesicle-Based Signaling in the Cardiovascular System